ES8503669A1 - Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. - Google Patents
Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.Info
- Publication number
- ES8503669A1 ES8503669A1 ES523609A ES523609A ES8503669A1 ES 8503669 A1 ES8503669 A1 ES 8503669A1 ES 523609 A ES523609 A ES 523609A ES 523609 A ES523609 A ES 523609A ES 8503669 A1 ES8503669 A1 ES 8503669A1
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- cor
- alkyl
- alkoxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR DERIVADOS N-IMIDAZOLILICOS DE COMPUESTOS BICICLICOS.CONSISTE EN SOMETER A REACCION DE BETA-ELIMINACION UN COMPUESTO DE FORMULA (II) PARA OBTENER DERIVADOS N-IMIDAZOLILICOS DE COMPUESTOS BICICLICOS DE FORMULA (I) Y SOMETER A UNA REACCION DE REDUCCION EL COMPUESTO DE FORMULA (I), DONDE EL SIMBOLO REPRESENTA UN ENLACE SIMPLE O DOBLE; Z ES UN ENLACE SIMPLE, UN ATOMO DE O O UN GRUPO -CH2-; R1, R2, R3 Y R4 SON H, HIDROXI, HALOGENO, 5-TETRAZOLILO Y OTROS; R5 Y R6 SON H, ALQUILO C 1 A 6, CICLOALQUILO Y OTROS; Y M ES H O UN DERIVADO ACTIVO DE UN ACIDO. SE REALIZA EN PRESENCIA DE UN DISOLVENTE ORGANICO A TEMPERATURA ENTRE 50JC Y LA TEMPERATURA DE REFLUJO.SE EMPLEAN COMO INHIBIDORES SOBRE LA TXA2-SINTETASA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8219412 | 1982-07-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES523609A0 ES523609A0 (es) | 1985-03-01 |
ES8503669A1 true ES8503669A1 (es) | 1985-03-01 |
Family
ID=10531484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES523609A Expired ES8503669A1 (es) | 1982-07-05 | 1983-06-27 | Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. |
Country Status (33)
Country | Link |
---|---|
US (2) | US4510149A (es) |
JP (1) | JPS5927874A (es) |
KR (1) | KR910000414B1 (es) |
AT (1) | AT386201B (es) |
AU (1) | AU557304B2 (es) |
BE (1) | BE897207A (es) |
CA (1) | CA1202030A (es) |
CH (1) | CH655102A5 (es) |
CS (1) | CS273310B2 (es) |
CZ (1) | CZ413491A3 (es) |
DE (1) | DE3324069C2 (es) |
DK (1) | DK163359C (es) |
ES (1) | ES8503669A1 (es) |
FI (1) | FI74466C (es) |
FR (1) | FR2529547B1 (es) |
GR (1) | GR77577B (es) |
HK (1) | HK101187A (es) |
HU (1) | HU193529B (es) |
IE (1) | IE55894B1 (es) |
IL (1) | IL69152A0 (es) |
IT (1) | IT1163641B (es) |
LU (1) | LU84895A1 (es) |
MY (1) | MY104376A (es) |
NL (1) | NL8302347A (es) |
NO (1) | NO161439C (es) |
NZ (1) | NZ204802A (es) |
PH (1) | PH21115A (es) |
PT (1) | PT76979B (es) |
SE (1) | SE461791B (es) |
SG (1) | SG73487G (es) |
SU (1) | SU1342414A3 (es) |
YU (1) | YU43545B (es) |
ZA (1) | ZA834865B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
JPH062745B2 (ja) * | 1984-07-16 | 1994-01-12 | 第一製薬株式会社 | インダン誘導体 |
US4659730A (en) * | 1984-06-18 | 1987-04-21 | Eli Lilly And Company | Aromatase inhibiting imidazole derivatives |
GB2167408B (en) * | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
GB8612796D0 (en) * | 1986-05-27 | 1986-07-02 | Fbc Ltd | Fungicides |
JPS63310825A (ja) * | 1987-06-03 | 1988-12-19 | フアルミタリア・カルロ・エルバ・エツセ・エルレ・エルレ | 医薬に有用な二環式化合物のn−イミダゾリル誘導体 |
US4992465A (en) * | 1988-09-27 | 1991-02-12 | Ciba-Geigy Corporation | 3-amino-dihydro-(1)-benzopyrans |
IL91542A0 (en) * | 1988-10-06 | 1990-04-29 | Erba Carlo Spa | N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them |
GB9025848D0 (en) * | 1990-11-28 | 1991-01-09 | Erba Carlo Spa | Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
GB9102862D0 (en) * | 1991-02-11 | 1991-03-27 | Erba Carlo Spa | N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans |
GB9127050D0 (en) * | 1991-12-20 | 1992-02-19 | Orion Yhtymae Oy | Substituted imidazole derivatives and their preparation and use |
GB9127430D0 (en) * | 1991-12-27 | 1992-02-19 | Scras | Benzofuranylimidazole derivatives |
US5837702A (en) * | 1993-10-07 | 1998-11-17 | Bristol-Myers Squibb Co. | 4-arylamino-benzopyran and related compounds |
US5559248A (en) * | 1995-04-05 | 1996-09-24 | Bristol-Myers Squibb Co. | Retinoid-like heterocycles |
US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
US5612323A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phosphinic ester substituted benzopyran derivatives |
GB9520150D0 (en) | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
GC0000177A (en) * | 1998-12-17 | 2006-03-29 | Smithkline Beecham | Thrombopoietin mimetics |
CY2010012I2 (el) * | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
US20110212054A1 (en) * | 2000-05-25 | 2011-09-01 | Glaxosmithkline Llc. | Thrombopoietin mimetics |
DE10054639B4 (de) * | 2000-11-03 | 2004-05-06 | Jenapharm Gmbh & Co. Kg | Verwendung von RanBPM als Co-Modulator von Steroidhormonrezeptoren |
JP2004527541A (ja) | 2001-03-01 | 2004-09-09 | スミスクライン・ビーチャム・コーポレイション | トロンボポエチン模倣物 |
MY142390A (en) * | 2002-05-22 | 2010-11-30 | Glaxosmithkline Llc | 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
WO2004092141A1 (en) * | 2003-04-16 | 2004-10-28 | Huntsman Advanced Materials (Switzerland) Gmbh | 1-imidazolymethyl-substituted-2-naphtols and their use as accelerators for low-temperature curing |
TW200526638A (en) * | 2003-10-22 | 2005-08-16 | Smithkline Beecham Corp | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
US9271963B2 (en) * | 2005-03-03 | 2016-03-01 | Universitat Des Saarlandes | Selective inhibitors of human corticosteroid synthases |
CA2672286A1 (en) * | 2006-12-18 | 2008-06-26 | Novartis Ag | Organic compounds |
ECSP077628A (es) * | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
EP3127427B1 (en) | 2009-05-29 | 2020-01-08 | Novartis Ag | Methods of administration of thrombopoietin agonist compounds |
WO2016022448A1 (en) * | 2014-08-08 | 2016-02-11 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2443671A (en) * | 1942-12-03 | 1948-06-22 | Westinghouse Electric Corp | Arc welding system |
US3485917A (en) * | 1966-04-14 | 1969-12-23 | Janssen Pharmaceutica Nv | Composition and method for combating fungus with imidazole carboxylates |
US3541109A (en) * | 1968-06-25 | 1970-11-17 | Du Pont | 1-substituted imidazoles useful in acth reserve assay |
US3637731A (en) * | 1968-07-18 | 1972-01-25 | Du Pont | 1-(alkylsubstituted phenyl)imidazoles useful in acth reserve assay |
IE40911B1 (en) * | 1974-04-11 | 1979-09-12 | Schering Ag | Imidazole derivatives and process for their manufacture |
DE2418502C3 (de) * | 1974-04-11 | 1980-04-24 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4284641A (en) * | 1977-08-26 | 1981-08-18 | Burroughs Wellcome Co. | Pharmaceutically active imidazole derivatives |
JPS55313A (en) * | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
JPS5681566A (en) * | 1979-12-05 | 1981-07-03 | Yoshitomi Pharmaceut Ind Ltd | Imidazole derivative |
DE3167014D1 (en) * | 1980-02-14 | 1984-12-13 | Sandoz Ag | A method for the total synthesis of cyclosporins and novel cyclosporins |
GB2071655B (en) * | 1980-03-04 | 1983-06-22 | Erba Farmitalia | N-amidazolyl derivatives of1-chroman and process for their preparation |
ZA81980B (en) * | 1980-03-04 | 1982-02-24 | Erba Farmitalia | N-imidazolyl derivatives of 1-chroman and process for their preparation |
IL62122A0 (en) * | 1980-03-04 | 1981-03-31 | Erba Farmitalia | N-imidazolyl derivatives of 1-chroman,their preparation and pharmaceutical compositions containing them |
ZA825142B (en) * | 1981-07-23 | 1983-04-27 | Erba Farmitalia | N-imidazolyl derivatives of 1,2,3,j-tetrahydro-naphthalene, indan and 2-substituted-1-chroman, and process for their preparation |
IL66242A0 (en) * | 1981-07-23 | 1982-11-30 | Erba Farmitalia | N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them |
ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
JPS6081566A (ja) * | 1983-10-07 | 1985-05-09 | Nissan Motor Co Ltd | ロツクアツプトルクコンバ−タのスリツプ制御装置 |
-
1983
- 1983-06-27 ES ES523609A patent/ES8503669A1/es not_active Expired
- 1983-07-01 PH PH29170A patent/PH21115A/en unknown
- 1983-07-01 YU YU1442/83A patent/YU43545B/xx unknown
- 1983-07-01 GR GR71829A patent/GR77577B/el unknown
- 1983-07-01 NL NL8302347A patent/NL8302347A/nl not_active Application Discontinuation
- 1983-07-01 US US06/510,358 patent/US4510149A/en not_active Expired - Fee Related
- 1983-07-01 FI FI832420A patent/FI74466C/fi not_active IP Right Cessation
- 1983-07-01 IT IT21886/83A patent/IT1163641B/it active
- 1983-07-04 PT PT76979A patent/PT76979B/pt unknown
- 1983-07-04 JP JP58120440A patent/JPS5927874A/ja active Granted
- 1983-07-04 AU AU16540/83A patent/AU557304B2/en not_active Ceased
- 1983-07-04 SE SE8303824A patent/SE461791B/sv not_active IP Right Cessation
- 1983-07-04 CA CA000431748A patent/CA1202030A/en not_active Expired
- 1983-07-04 FR FR8311098A patent/FR2529547B1/fr not_active Expired
- 1983-07-04 IL IL69152A patent/IL69152A0/xx not_active IP Right Cessation
- 1983-07-04 SU SU833622805A patent/SU1342414A3/ru active
- 1983-07-04 HU HU832413A patent/HU193529B/hu not_active IP Right Cessation
- 1983-07-04 DK DK307983A patent/DK163359C/da not_active IP Right Cessation
- 1983-07-04 IE IE1564/83A patent/IE55894B1/en not_active IP Right Cessation
- 1983-07-04 NZ NZ204802A patent/NZ204802A/en unknown
- 1983-07-04 BE BE0/211113A patent/BE897207A/fr not_active IP Right Cessation
- 1983-07-04 LU LU84895A patent/LU84895A1/fr unknown
- 1983-07-04 NO NO832437A patent/NO161439C/no unknown
- 1983-07-04 CH CH3666/83A patent/CH655102A5/de not_active IP Right Cessation
- 1983-07-04 DE DE3324069A patent/DE3324069C2/de not_active Expired - Fee Related
- 1983-07-04 ZA ZA834865A patent/ZA834865B/xx unknown
- 1983-07-05 KR KR1019830003067A patent/KR910000414B1/ko not_active IP Right Cessation
- 1983-07-05 AT AT0247383A patent/AT386201B/de not_active IP Right Cessation
- 1983-07-05 CS CS509483A patent/CS273310B2/cs unknown
-
1984
- 1984-11-21 US US06/673,722 patent/US4602022A/en not_active Expired - Fee Related
-
1987
- 1987-09-03 SG SG734/87A patent/SG73487G/en unknown
- 1987-12-31 HK HK1011/87A patent/HK101187A/xx unknown
-
1988
- 1988-12-30 MY MYPI88001593A patent/MY104376A/en unknown
-
1991
- 1991-12-30 CZ CS914134A patent/CZ413491A3/cs unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8503669A1 (es) | Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos. | |
TW282466B (es) | ||
NO170280C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater | |
PL275423A1 (en) | Method of obtaining novel heterocyclic compounds | |
HUT52059A (en) | Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components | |
ES8703410A1 (es) | Procedimiento para preparar guanidinas anti-inflamatorias | |
DE3363743D1 (en) | Dihydropyridine anti-ischaemic and antihypertensive agents | |
PH20114A (en) | Dihydropyridines,pharmaceutical compositions containing the same and method of use thereof | |
ES8500233A1 (es) | Un metodo para preparar compuestos de piridilo | |
ATE67193T1 (de) | 6-phenyl-pyridazin-verbindungen. | |
PT87277A (pt) | Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same | |
ES8307792A1 (es) | Un metodo de produccion de compuesto de dihidropiridina. | |
ES8403887A1 (es) | Procedimiento de obtencion de los 2-amino 5- (aralcoil piperidino alcoil) amino 1,4-diazoles | |
ES8401755A1 (es) | Procedimiento para la preparacion de derivados de tiometilpiridina. | |
ES2006361A6 (es) | Un procedimiento para preparar derivados de insoindolinilo opticamente activos. | |
ES8604958A1 (es) | Un procedimiento de obtencion de imidazoquinolinas | |
ES8103092A1 (es) | Un procedimiento para la preparacion de derivados del acido aminodesoxi-clavulanico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970519 |